WASHINGTON DC (August 12, 2019) — Senator Charles "Chuck" Grassley, chairman of the Senate Finance Committee, sent a letter to Novartis International AG CEO Vasant Narasimhan requesting documents relating to AveXis, a subsidiary of Novartis, manipulating data about a treatment for infants suffering from spinal muscular atrophy.







